MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202611112095 A) filed by Noida Institute Of Engineering And Technology Pharmacy Institute on September 18, 2026, for Cd44-Targeted Magneto-Sonoresponsive Nanocapsule For Platinum-Resistant Ovarian Carcinoma.
Inventors include Dr. Priyanka Bansal; and Anmol Dogra.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: The present invention discloses a CD44-targeted magneto-sonoresponsive polymer-lipid hybrid nanocapsule having a diameter of 100 to 150 nanometres for platinum- resistant ovarian carcinoma. The nanocapsule comprises a superparamagnetic iron-oxide core embedded in a perfluorohexane sonosensit...